Skip to main content
Clinical Trials/NL-OMON43100
NL-OMON43100
Completed
Not Applicable

Continuous glucose monitoring during diets that differ in glycemic load - GLOW<br>Glucose LOWering

nilever0 sites23 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Metabolisme
Sponsor
nilever
Enrollment
23
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
nilever

Eligibility Criteria

Inclusion Criteria

  • \- Apparently healthy men and post\-menopausal women (post\-menopausal for at least one year)
  • \- BMI \>\= 25\.0 and \<\= 35\.0 kg/m2
  • \- Age: 50\-70 yrs
  • \- Signed informed consent

Exclusion Criteria

  • \- Having a medical conditions which might affect the study measurements.
  • \- Reported use of over\-the\-counter or prescribed medication or food supplements, which may interfere with study measurements.
  • \- Use of oral antibiotics 40 days or less prior to the start of the study
  • \- Reported participation in another nutritional or biomedical study 3 months before the screening or during the study
  • \- Reported participation in night shift work 2 weeks prior to screening or during the study.
  • \- Reported intense sporting activities \> 2h/w.
  • \- Reported alcohol consumption \> 10 units/week (female) or \> 14 units/week (male)
  • \- Reported use of any nicotine containing products in the 6 months preceding the study and willing to abstain from use of nicotine containing products during the study.
  • \- Reported dietary habits: medically prescribed diet, slimming diet, vegetarian.
  • \- Reported weight loss/gain (\> 3 kg) in the last 2 months before the study.

Outcomes

Primary Outcomes

Not specified

Similar Trials